PMID: 2110198May 1, 1990Paper

Cromolyn sodium in the management of systemic mastocytosis

The Journal of Allergy and Clinical Immunology
R F HoranK F Austen

Abstract

A multicenter, double-blind, placebo-controlled trial of the efficacy of oral cromolyn sodium (200 mg orally four times per day) was conducted in 11 patients with systemic mastocytosis who had been maintained with the drug on an individualized compassionate-need basis. Efficacy was measured by physician assessment of overall disease severity based on history and physical examination at specified intervals and by the average daily patient symptom diary scores for each of three mastocytosis-related symptoms that had previously appeared to be alleviated by the use of this drug. Efficacy variables were compared for a 4-week baseline period, during which patients received open-labeled cromolyn sodium, and at 4-week intervals during a 16-week period of random assignment to cromolyn sodium or placebo. Overall disease severity and symptoms recorded in patient diaries were graded on a scale of 0 (absent) to 5 (incapacitating). The average physician assessment of disease severity and symptom scores of the patients in the placebo-treated group increased significantly during the randomization phase relative to patients in the cromolyn sodium-treated group, reflecting an exacerbation of symptoms with drug withdrawal (p less than 0.05 and le...Continue Reading

Citations

Feb 18, 2010·Inflammatory Bowel Diseases·Harry SokolOlivier Hermine
Jan 1, 1995·International Journal of Clinical & Laboratory Research·A GenoveseG Marone
Aug 29, 2012·Seminars in Immunopathology·Simon P HoganFred D Finkelman
May 30, 2001·Leukemia Research·P ValentJ M Bennett
May 30, 2001·Leukemia Research·G MaroneM Triggiani
Jul 26, 2000·Hematology/oncology Clinics of North America·N A Soter
Jun 30, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jill A PooleRohit K Katial
Aug 5, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·G R StentonA D Befus
Apr 12, 2001·The British Journal of Dermatology·K Hartmann, B M Henz
Sep 29, 2001·Pediatric Dermatology·E GülerM Büyükpamukçu
Apr 2, 2008·The Journal of Experimental Medicine·Elizabeth E ForbesSimon P Hogan
Apr 24, 2002·Archives of Disease in Childhood·M C Carter, D D Metcalfe
Jan 1, 2011·BMJ Case Reports·Alan Martin Edwards, Stepánka Capková
Jan 30, 2004·Annual Review of Medicine·Cem Akin, Dean D Metcalfe
Jun 29, 2010·Journal of Medical Case Reports·Alan M Edwards, Hans Hagberg
Jun 15, 2011·American Journal of Clinical Dermatology·Mariana CastellsLuis Escribano
May 10, 1997·Lancet·L Golkar, J D Bernhard
Feb 4, 2014·Pharmacology & Therapeutics·Laurent L Reber, Nelly Frossard
Apr 3, 2012·Digestive Diseases and Sciences·David F SchaefferRobert H Riddell
Jul 22, 2015·Gut·Mira M WoutersJavier Santos
Jan 5, 2002·The Journal of Investigative Dermatology. Symposium Proceedings·K HartmannB M Henz
Jan 5, 2002·The Journal of Investigative Dermatology. Symposium Proceedings·L Juhlin
May 24, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A Edwards
Sep 1, 1993·Journal of Clinical Epidemiology·J A KopecJ M Esdaile
Sep 19, 2015·Clinical Lymphoma, Myeloma & Leukemia·Douglas TremblayJohn Mascarenhas
Jun 20, 2006·Best Practice & Research. Clinical Haematology·A PardananiP Valent
Jul 26, 2000·Hematology/oncology Clinics of North America·K Hartmann, D D Metcalfe
Jul 26, 2000·Hematology/oncology Clinics of North America·A S Worobec
May 4, 2004·Immunology and Allergy Clinics of North America·Knut Brockow
Jan 17, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Michail AlevizosTheoharis C Theoharides
Aug 22, 2003·British Journal of Haematology·Peter ValentDean D Metcalfe
Mar 11, 2015·European Journal of Haematology·Michel ArockPeter Valent
Sep 21, 2013·Expert Opinion on Pharmacotherapy·Juan Carlos CardetMin Jung Lee
Jul 15, 2015·The New England Journal of Medicine·Theoharis C TheoharidesCem Akin
Dec 17, 2014·The Journal of Allergy and Clinical Immunology·Zuyi WengTheoharis C Theoharides
Apr 27, 2016·The Journal of Cell Biology·Dustin Green, Xinzhong Dong
May 2, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Gerhard J MolderingsLawrence B Afrin
Sep 17, 2015·Journal of the American Society of Nephrology : JASN·Poh-Yi GanStephen R Holdsworth
Nov 1, 2016·Archivum Immunologiae Et Therapiae Experimentalis·Anca Maria Cimpean, Marius Raica
Mar 1, 1991·The Journal of Investigative Dermatology·R F Horan, K F Austen
Mar 1, 1991·The Journal of Investigative Dermatology·N A Soter
Mar 1, 1991·The Journal of Investigative Dermatology·B V Kettelhut, D D Metcalfe
Aug 23, 2016·Primary Care·Ayesha AbidKatherine Curci
Jul 11, 2006·Clinics in Dermatology·Serge A JabbourRonni Wolf
Jul 31, 2013·The Journal of Allergy and Clinical Immunology·Harry SokolOlivier Hermine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Dermatology : International Journal for Clinical and Investigative Dermatology
O GodtE Christophers
The Journal of Allergy and Clinical Immunology
J TurkL J Roberts
© 2021 Meta ULC. All rights reserved